Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
08/19/2014 | US8808743 Benzonatate compositions and methods of use |
08/19/2014 | US8808742 Compositions and methods for preparing and using same |
08/19/2014 | US8808741 Tamper resistant dosage forms |
08/19/2014 | US8808740 Encased tamper resistant controlled release dosage forms |
08/19/2014 | US8808739 Orodispersible tablet containing compacted sildenafil base |
08/19/2014 | US8808738 Aliphatic amine polymer salts for tableting |
08/19/2014 | US8808737 Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment |
08/19/2014 | US8808736 Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
08/19/2014 | US8808735 Fast wet-massing method for the preparation of calcium-containing compositions |
08/19/2014 | US8808734 Cannabinoid formulations |
08/19/2014 | US8808733 Method of controlled drug release from a liposome carrier |
08/19/2014 | US8808732 Film forming personal care compositions and methods |
08/19/2014 | US8808731 Adhesive pharmaceutical preparation containing bisoprolol |
08/19/2014 | US8808729 Multilayered transmucosal therapeutic system |
08/19/2014 | US8808725 Solid forms for tissue repair |
08/19/2014 | US8808718 Hypertonic organic acid or salt thereof disinfectant composition and its use in dental treatment |
08/19/2014 | US8808716 Topical foam composition |
08/19/2014 | US8808715 Methods and compositions for modulating keratinocyte function |
08/19/2014 | US8808714 Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics |
08/19/2014 | US8808713 Compositions for pulmonary delivery of long-acting β2 adrenergic receptor agonists and associated methods and systems |
08/19/2014 | US8808687 Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same |
08/19/2014 | US8808669 Gastroretentive, extended release composition of therapeutic agent |
08/19/2014 | US8808664 Lipidated glycoprotein particles and methods of use |
08/19/2014 | US8808276 Adaptive dispensation in a digestive tract |
08/19/2014 | US8808268 Method and composition for hyperthermally treating cells |
08/19/2014 | US8808257 Methods and apparatus for pulsatile release of medicaments from a punctal plug |
08/19/2014 | US8808219 Implant delivery device and methods thereof for treatment of ocular disorders |
08/19/2014 | US8807979 Machine for the manufacture of dosage forms utilizing radiofrequency energy |
08/19/2014 | CA2760555C Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine |
08/19/2014 | CA2717494C Compressed tablets |
08/19/2014 | CA2691571C An inhalable composition |
08/19/2014 | CA2646289C Wound dressings with anti-microbial and zinc-containing agents |
08/19/2014 | CA2642479C A gastro-retentive system for the delivery of macromolecules |
08/19/2014 | CA2637874C Patch and adhesive preparation |
08/19/2014 | CA2626881C Biodegradable particle and production method thereof |
08/19/2014 | CA2609579C Stable liquid desoximetasone compositions with reduced oxidized impurity |
08/19/2014 | CA2596529C Hydrophilic biocompatible adhesive formulations and uses |
08/19/2014 | CA2574437C Infusion and injection solution of levodopa |
08/19/2014 | CA2569968C Controlled release matrix pharmaceutical dosage formulation |
08/19/2014 | CA2565221C Biodegradable intravitreal tyrosine kinase inhibitors implants |
08/19/2014 | CA2514294C Medical data communication notification and messaging system and method |
08/19/2014 | CA2434409C Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof |
08/19/2014 | CA2426200C Inhibition or reversal of skin aging by actin-sequestering peptides |
08/14/2014 | WO2014124304A1 System and method using precious-metal nanoparticle contrast agent for microwave medical imaging |
08/14/2014 | WO2014124151A1 Methods for rapidly treating severe hypoglycemia |
08/14/2014 | WO2014124132A1 Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery |
08/14/2014 | WO2014124096A1 Stable glucagon formulations |
08/14/2014 | WO2014123977A1 Geranylgeranylacetone formulations |
08/14/2014 | WO2014123899A1 Tamper resistant pharmaceutical formulations |
08/14/2014 | WO2014123500A1 Pharmaceutical formulations comprising cefpodoxime proxetil and clavulanic acid |
08/14/2014 | WO2014123355A1 Orally administered celecoxib composition |
08/14/2014 | WO2014123244A1 Solid dispersion comprising amorphous cilostazol |
08/14/2014 | WO2014122586A1 Oral pharmaceutical composition of aliphatic amine polymer or salts thereof |
08/14/2014 | WO2014122585A1 A stable pharmaceutical composition of amlodipine and benazepril or salts thereof |
08/14/2014 | WO2014122563A1 An intra vaginal device, and a method of reducing the rate of diffusion of active ingredients in said intra vaginal device |
08/14/2014 | WO2014122460A2 Pemetrexed complexes and pharmaceutical compositions containing pemetrexed complexes |
08/14/2014 | WO2014122444A1 Permeation enhanced active-carrying nanoparticles |
08/14/2014 | WO2014122436A1 Topical pharmaceutical compositions comprising minoxidil |
08/14/2014 | WO2014122248A1 Kit-of-parts |
08/14/2014 | WO2014122232A1 Pharmaceutical compositions comprising vesicles |
08/14/2014 | WO2014122195A1 Pharmaceutical compositions incorporating low-dose drugs |
08/14/2014 | WO2014122024A1 Topical antifungal composition for treating onychomycosis |
08/14/2014 | WO2014121378A1 Conductive biomaterial for enhancement of conduction in vitro and in vivo |
08/14/2014 | WO2014121342A1 Methods of treating topical microbial infections |
08/14/2014 | WO2014104989A8 Pharmaceutical compositions comprising aripiprazole |
08/14/2014 | WO2014096440A3 Albumin composition for preventing and/or reducing formation of peptide fibrils |
08/14/2014 | WO2013111100A9 Stable amorphous raltegravir potassium premix and process for the preparation thereof |
08/14/2014 | US20140228747 Recessed Bolus |
08/14/2014 | US20140228444 Otic composition for companion animals |
08/14/2014 | US20140228437 Pharmaceutical composition |
08/14/2014 | US20140228430 Method of Accelerating Corneal Wound Healing |
08/14/2014 | US20140228397 Propellant-free aerosol formulation for inhalation |
08/14/2014 | US20140228390 Pharmaceutical Formulation Containing Gelling Agent |
08/14/2014 | US20140228389 Dry powder compound formulations and uses thereof |
08/14/2014 | US20140228354 Method for Inhibition of Deubiquitinating Activity |
08/14/2014 | US20140228335 Ulipristal Acetate Tablets |
08/14/2014 | US20140228287 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-axanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal |
08/14/2014 | US20140228280 Low impurity content caspofungin preparation, method for preparing same, and use thereof |
08/14/2014 | US20140227366 Carrier material for improving the persistance of biocides |
08/14/2014 | US20140227364 Methods of manufacturing bioactive gels from extracellular matrix material |
08/14/2014 | US20140227360 Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery |
08/14/2014 | US20140227358 Organic compounds |
08/14/2014 | US20140227357 Fill formulations and capsules and method of use to avoid migration of fill into or through the shell |
08/14/2014 | US20140227356 Composite formulation comprising a tablet encapsulated in a hard capsule |
08/14/2014 | US20140227351 Taste masked pharmaceutical composition |
08/14/2014 | US20140227349 Vesicle Compositions |
08/14/2014 | US20140227348 Peptides that target dorsal root ganglion neurons |
08/14/2014 | US20140227345 Components for producing amphoteric liposomes |
08/14/2014 | US20140227343 Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles |
08/14/2014 | US20140227340 Fibers Comprising Poorly Soluble Drugs and/or Proteins |
08/14/2014 | US20140227339 Regenerative tissue grafts and methods of making same |
08/14/2014 | US20140227330 Capsule whose envelope is separately imperceptible during the topical use thereof |
08/14/2014 | US20140227327 Injectable Cryogel Vaccine Devices and Methods of Use Thereof |
08/14/2014 | US20140227326 Method of delivering nasal spray |
08/14/2014 | US20140227318 Sleep quality improving agent |
08/14/2014 | US20140227274 Prevention and Treatment of Amyloidogenic Disease |
08/14/2014 | US20140227199 Penetrating pharmaceutical foam |
08/14/2014 | US20140227197 Compositions for Treatment of Attention Deficit Hyperactivity Disorder |
08/14/2014 | US20140227194 Preparation for Restenosis Prevention |
08/14/2014 | US20140227193 Preparation for Restenosis Prevention |